trial · primary record
Cyclophosphamide
Select Advanced Solid Tumors
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 141 |
| Primary completion | 2041-08-01 |
| Primary endpoint | Safety and adverse events (AEs) |
| Registry ID | NCT06598371 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:03.816Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06598371
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Cyclophosphamide · approval
- Cyclophosphamide · compound